US OptionsDetailed Quotes
AOSL241220C22500
- 3.70
- 0.000.00%
15min DelayClose Dec 13 16:00 ET
0.00High0.00Low
3.70Open3.70Pre Close0 Volume2 Open Interest22.50Strike Price0.00Turnover407.54%IV-42.04%PremiumDec 20, 2024Expiry Date22.70Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9608Delta0.0041Gamma1.96Leverage Ratio-0.1778Theta0.0025Rho1.88Eff Leverage0.0043Vega
Alpha & Omega Semiconductor Stock Discussion
Sign in to post a comment
$Snowflake (SNOW.US)$ $Alpha & Omega Semiconductor (AOSL.US)$ $Quantum Computing (QUBT.US)$ $Osisko Development (ODV.US)$ $Safe Pro Group (SPAI.US)$ $Innovation Beverage Group (IBG.US)$ $T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ.US)$ $Defiance Daily Target 2X Short MSTR ETF (SMST.US)$ $Arqit Quantum (ARQQ.US)$ $Procaps (PROC.US)$ $Innovid (CTV.US)$ $Cerence (CRNC.US)$ $SCWorx (WORX.US)$
📊⚡️📊
📊⚡️📊
3
25
1. $NVIDIA (NVDA.US)$ CEO Jensen Huang recently stated that the company aims to release a new version of its flagship AI chip annually. While this strategy enhances Nvidia’s competitiveness, it presents execution challenges, most notably the need to accelerate the supplier certification process while simultaneously accelerating system de...
1
Alpha and Omega Semiconductor's low P/S ratio may be due to limited future growth expectations. The company's inferior revenue outlook contributes to its low P/S, as investors see insufficient potential for revenue improvement to justify a higher ratio.
Analysts suggest that the recent sell-off could be an investment opportunity with signs of a long-term growth trend. Insider buys could create a more favorable outlook for the company.
Despite AOSL's low return on equity compared to a 15% industry average, it saw remarkable net income growth due to strategic decisions and a low payout ratio. Continued growth is expected, indicating a bright future.
Gapping up
In reaction to earnings/guidance:
• $ChargePoint (CHPT.US)$ +2.8%, $Designer Brands (DBI.US)$ +1.8%, $Donaldson (DCI.US)$ +0.7%
Other news:
• $Cepton (CPTN.US)$ +9.2% (receives non-bindingLolfor a $100mln investment from Koito Manufacturing)
• $Sorrento Therapeutics (SRNE.US)$ +7.2% (receives FDA Fast Track Designation for SP-103(Lidocaine Topical System) 5.4%)
• $Mereo BioPharma (MREO.US)$ +6.7% (sends letter to Rubric Capital...
In reaction to earnings/guidance:
• $ChargePoint (CHPT.US)$ +2.8%, $Designer Brands (DBI.US)$ +1.8%, $Donaldson (DCI.US)$ +0.7%
Other news:
• $Cepton (CPTN.US)$ +9.2% (receives non-bindingLolfor a $100mln investment from Koito Manufacturing)
• $Sorrento Therapeutics (SRNE.US)$ +7.2% (receives FDA Fast Track Designation for SP-103(Lidocaine Topical System) 5.4%)
• $Mereo BioPharma (MREO.US)$ +6.7% (sends letter to Rubric Capital...
9
5
No comment yet
Krystian 1983 : Thanks great work
Stock_Drift OP Krystian 1983 : YW.
Chris yu216 : What does this mean for snowflake? Is it keep going up or pull back
Hatt bosdike Chris yu216 : Wait for a pullback hopefully tomorrow Friday. People will start taking profit.
Stock_Drift OP Hatt bosdike : Agreed. Appreciate it.
View more comments...